Kainic acid (KA)-induced seizures in Sprague-Dawley rats and the effect of dietary taurine (TAU) supplementation or deficiency

Amino Acids

Volumn 16, Issue 2, 1999, Pages 133-147

  Eppler, B ^a   Patterson, T A ^b   Zhou, W ^a   Millard, W J ^a   Dawson Jr , R ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Amino acids; Anticonvulsants; Epilepsy; Excitatory amino acids; Kainic acid; Neuroprotection; Taurine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; KAINIC ACID; TAURINE;

AMINO ACID BLOOD LEVEL; AMINO ACID DEFICIENCY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BINDING SITE; CONTROLLED STUDY; CORPUS STRIATUM; DIET SUPPLEMENTATION; FOCAL EPILEPSY; HIPPOCAMPUS; LATENT PERIOD; MALE; NEUROPROTECTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SEIZURE; TEMPORAL CORTEX; TONIC CLONIC SEIZURE;

EID: 0032960248     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01321532     Document Type: Article

References (53)

1. Bagley P, Hirschberger LL, Stipanuk MH (1995) Evaluation and modification of an assay procedure for cysteine dioxygenase activity: high-performance liquid chromatography method for measurement of cysteine sulfinate and demonstration of physiological relevance of cysteine dioxygenase activity in cysteine metabolism. Analyt Biochem 227: 40-48
2. 2-Adrenoceptors modulate kainic acid-induced limbic seizures. Eur J Pharmacol 113: 263-269
3. Baran H, Lassmann H, Sperk G, Seitelbeger F, Hornykiewicz O (1987) Effect of mannitol treatment on brain neurotransmitter markers in kainic acid-induced epilepsy. Neuroscience 21/3: 679-684
4. Barbeau A, Inoue N, Tsukada Y, Butterworth RF (1975) The neuropharmacology of taurine. Life Sci 17: 669-678
5. Ben-Ari Y (1985) Limbic seizure and brain damage produced by kainic-acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14/2: 375-403
6. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
7. Davison AN, Kaczmarek LK (1971) Taurine-a possible neurotransmitter. Nature 234: 107-108
8. 2-adrenergic agonists on renal function in Long-Evans and Brattleboro rats. Pharmacology 39: 240-252
9. Dawson Jr R, Wallace DR (1992a) Taurine content in tissues from aged Fischer 344 rats. Age 15: 73-81
10. Dawson Jr R, Wallace DR (1992b) Kainic acid-induced seizures in aged rats: neurochemical correlates. Brain Res Bull 29: 459-468
11. Dawson Jr R, Eppler B, Patterson TA, Shih D, Liu S (1996) The effect of taurine in a rodent model of aging. In: Huxtable RJ et al (eds) Taurine 2. Plenum Press, New York, pp 37-50
12. Dixon WJ, Massey FJ (1969) Introduction to statistical analysis. McGraw-Hill, New York
13. Durelli L, Mutani R, Quattrocolo G, Delsedime M, Buffa C, Fassio F, Valentini C, Fumero S (1977) Relationships between electroencephalographic pattern and biochemical picture of the cobalt epileptogenic lesion after cortical superfusion with taurine. Exp Neurol 54: 489-503
14. Durelli L, Mutani R, Delsedime M, Quattrocolo G, Buffa C, Mazzarino M, Fumero S (1979) Electroencephalographic and biochemical study of the antiepileptic actions of taurine administered by cortical superfusion. Exp Neurol 52: 30-39
15. Eppler B, Dawson Jr R (1998) The effects of aging on taurine content and biosynthesis in different strains of rats. In: Huxtable RJ et al (eds) Taurine 3. Plenum Press, New York, pp 55-61
16. Fariello RG, Golden GT, Pisa M (1982) Homotaurine (3 aminopropanesulfonic acid; 3APS) protects from the convulsant and cytotoxic effect of systematically administered kainic acid. Neurology 32: 241-245
17. Gaull GE (1989) Taurine in pediatric nutrition: review and update. Pediatrics 83/3: 433-442
18. Green P, Dawson Jr R, Wallace D, Owens J (1998) Treatment of rat brain membranes with taurine increases radioligand binding. In: Huxtable RJ et al (eds) Taurine 3. Plenum Press, New York, pp 377-383
19. Han X, Budreau AM, Chesney RW (1997) Functional expression of rat renal cortex taurine transporter in Xenopus leavis oocytes: adaptive regulation by dietary manipulation. Pediatr Res 41/5: 624-631
20. Hope DB (1957) The persistence of taurine in the brain of pyridoxine-deficient rats. J Neurochem 1: 364-369
21. Huxtable RJ (1989) Taurine in the central nervous system and the mammalian actions of taurine. Prog Neurobiol 32: 471-533
22. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72/2: 101-163
23. Izumi K, Igisu H, Fukuda T (1974) Suppression of seizures by taurine-specific or non-specific? Brain Res 76: 171-173
24. Izumi K, Igisu H, Fukuda T (1975) Effects of edetate on seizure suppressing actions of taurine and GABA. Brain Res 88: 576-579
25. Jacobsen JG, Smith LH Jr (1968) Biochemistry and physiology of taurine and taurine derivatives. Physiol Rev 48/2: 424-511
26. Killian M, Frey HH (1973) Central monoamines and convulsive thresholds in mice and rats. Neuropharmacol 12: 681-692
27. Kontur P, Dawson JR R, Monjan AA (1984) Manipulation of mobile phase parameters for HPLC separation of endogenous monoamines in rat brain tissue. J Neurosci Methods 11: 5-18
28. Lehman A (1987) Pentylenetetrazol seizure threshold and extracellular levels of cortical amino acids in taurine-deficient kittens. Act Physiol Scand 131: 453-458
29. Lombardini JB (1992) Review: Recent studies on taurine in the central nervous system. In: Lombardini JB (ed) Taurine. Plenum Press, New York, pp 245-251
30. Malcangio M, Bartolini A, Ghelardini C, Bennardini F, Malmberg-Aiello P, Franconi F, Giotto A (1989) Effects of ICV taurine on the impairment of learning, convulsions and death caused by hypoxia. Psychopharmacology 98: 316-320
31. McGeer PL, McGeer EG (1982) Kainic acid: the neurotoxic breakthrough. Crit Rev Toxicol 10/1: 1-26
32. Menendez N, Herreras O, Solis JM, Herranz AS, Del Rio RM (1989) Extracellular taurine increase in rat hippocampus evoked by specific glutamate receptor activation is related to the excitatory potency of glutamate agonists. Neurosci Lett 102: 64-69
33. Mutani R, Bergamini L, Fariello R, Delsedime M (1974) Effects of taurine on cortical acute epileptic foci. Brain Res 70: 170-173
34. Nadler JV (1981) Kainic acid as a tool for the study of temporal lobe epilepsy. Life Sci 29: 2031-2042
35. Nelson MF, Zazcek R, Coyle JT (1980) Effects of sustained seizures produced by intrahippocampal injection of kainic acid on noradrenergic neurons: evidence for local control of norepinephrine release. J Pharmacol Exp Ther 214: 694-702
36. 6-avitaminotischer Ratten nach Ganzkörperbestrahlung. Biochem Zeitschr 333: 226-235
37. Oja SS, Kontro P (1983) Taurine. In: Lajtha A (ed) Handbook of neurochemistry, vol 3. Plenum, New York, pp 501-533
38. Olney JW, Rhee V, Lan Ho O (1974) Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res 77: 507-512
39. Palkovits M, Banay-Schwartz M, Lajtha A (1990) Taurine levels in brain nuclei of young adult and aging rats. In: Taurine: functional neurochemistry, physiology, and cardiology. Wiley-Liss, Inc. New York, pp 45-51
40. Sanberg PR, Staines W, McGeer EG (1979) Chronic taurine effects on various neurochemical indices in control and kainic acid-lesioned neostriatum. Brain Res 161: 376-370
41. Schwob JE, Fuller T, Price JL, Olney JW (1980) Widespread patterns of neuronal damage following systemic or intracerebral injections of kainic acid: a histological study. Neuroscience 5: 991-1014
42. Sperk G, Lassmann H, Baran H, Seitelberger F, Hornykiewicz O (1985) Kainic acid-induced seizures: dose-relationship of behavioural, neurochemical and histopathological changes. Brain Res 338: 289-295
43. Sperk G (1994) Kainic acid seizures in the rat. Prog Neurobiol 42: 1-32
44. Stafstrom CE, Thompson JL, Holmes GL (1992) Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures. Dev Brain Res 65: 227-236
45. Tang XW, Deupree DL, Liu L, Wu JY (1996) Effect of GABA, taurine and chloride-channel blockers on excitatory amino acid-induced neurotoxicity. J Neurochem 66 [Suppl]1: S80
46. Uemura S, Ienaga K, Higashiura K, Kimura H (1991) Effects of intraamygdaloid injection of taurine and valyltaurine on amygdaloid kindled seizure in rats. Jpn J Psychiatry Neurol 45/2: 383-385
47. Van Gelder NM, Sherwin AL, Sacks C, Andermann F (1975) Biochemical observations following administration of taurine to patients with epilepsy. Brain Res 94: 297-306
48. Van Gelder NM (1978) Taurine, the compartmentalized metabolism of glutamic acid, and the epilepsies. Can J Physiol Pharmacol 56: 362-374
49. Velísek L, Kubová H, Velísková J, Mares P, Ortová M (1992) Action of antiepileptic drugs against kainic acid-induced seizures and automatisms during ontogenesis in rats. Epilepsia 33/6: 987-993
50. Wada JA, Osawa T, Wake A, Corcoran ME (1975) Effects of taurine on kindled amygdaloid seizures in rats, cats, and photosensitive baboons. Epilepsia 16: 229-234
51. Wade JV, Samson FE, Nelson SR, Pazdernik TL (1987) Changes in extracellular amino acids during soman-and kainic acid-induced seizures. J Neurochem 49/2: 645-649
52. Wozniak DF, Steward GR, Miller JP, Olney JW (1991) Age-related sensitivity to kainate neurotoxicity. Exp Neurol 114: 250-253
53. 5]enkephalinamide with reference to effects on hippocampal epileptic discharges. Neuropharmacology 25/12: 1373-1378